SILO PHARMA, INC. Net Investment Income
SILO PHARMA, INC. (SILO) reported Net Investment Income of -$20.88 thousand for the 3-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Income Statement › Other Income
us-gaap:NetInvestmentIncome · last filed 2014-03-31
- SILO PHARMA, INC. net investment income for the quarter ending 2013-12-31 was -$20.88K.
| Period end | Net Investment Income 3 month |
|---|---|
| 2013-12-31 | -$20.88K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |